France's public health system will soon start to cover most of the cost of weight-loss drugs Wegovy and Mounjaro for severely obese patients.

Ces nouveaux traitements anti-obésité, Wegovy et Mounjaro, devenus des phénomènes planétaires, doivent être remboursés bientôt en France par l'Assurance maladie.

The French state will soon partially reimburse the cost of weight-loss drugs Wegovy and Mounjaro for severely obese patients, expanding access to the expensive drugs, two informed…